| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $0.8B | $2.8B | $2.7B | $2.7B | $2.2B | $0.5B | $0.5B |
| Cost of Revenue | — | — | $0.1B | $0.1B | $0.1B | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $0.5B | $0.6B | $0.4B | $0.4B | $0.4B | $0.1B | $0.1B |
| EPS (Basic) | $22.95 | $4.97 | $15.97 | $9.77 | $9.41 | $9.60 | $2.25 | $1.99 |
| EPS (Diluted) | $22.91 | $4.96 | $15.94 | $9.74 | $9.38 | $9.57 | $2.24 | $1.99 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.0B | $14.6B | $15.0B | $15.3B | $16.1B | $14.9B | $13.7B | $12.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.7B | $0.6B | $0.5B | $0.4B | $0.5B | $0.3B | $0.3B |
| Total Liabilities | $12.6B | $12.3B | $13.0B | $13.6B | $14.0B | $13.1B | $12.0B | $11.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.4B | $2.3B | $2.1B | $1.7B | $2.1B | $1.8B | $1.7B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.7B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.1B | $-0.2B | $-0.9B | $-0.1B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.6B | $-0.5B | $-0.5B | $0.1B | $-0.3B | $-0.3B | $-0.3B |